Two prognostic populations of ovarian cancer patients defined by CA125 modeled kinetic parameter KELIM (AGO-OVAR 7 & 9; ICON 7 AGO/GINECO/MRC CTU/GCIG trials).

被引：2
|
作者：
You, Benoit
Colomban, Olivier
Freyer, Gilles
Leary, Alexandra
Ray-Coquard, Isabelle Laure
Lortholary, Alain
Bessard, Anne Claire Hardy
Pfisterer, Jacobus
Du Bois, Andreas
Kurzeder, Christian
Burges, Alexander
Tod, Michel
机构：
[1] IC HCL, CITOHL, Lyon, France
[2] Lab EMR3738 Ciblage Therapeut Oncol, Oullins, France
[3] Ctr Hosp Lyon Sud, Pierre Benite, France
[4] Gustave Roussy Canc Campus, Villejuif, France
[5] Ctr Leon Berard, Lyon, France
[6] Hop Prive Confluent, Nantes, France
[7] Ctr Armoricain Oncol, Plerin, France
[8] Gynecol Oncol Ctr, Kiel, Germany
[9] AGO, Essen, Germany
[10] Kliniken Essen Mitte, Essen, Germany
[11] AGO, Basel, Switzerland
[12] Univ Hosp Basel, Basel, Switzerland
[13] AGO, Munich, Germany
[14] Univ Hosp Munich Grosshadern, Dept Gynecol, Munich, Germany
[15] Univ Claude Bernard Lyon 1, Fac Med & Maieut Lyon Sud Charles Merieux, EMR 3738, Ciblage Therapeut Oncol, Oullins, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.5554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5554
引用
收藏
页数：3
相关论文
共 4 条
  • [1] Early prediction of the platinum-resistant relapse risk using the CA125 modeled kinetic parameter KELIM: A pooled analysis of AGO-OVAR 7 & 9; ICON 7 (AGO/GINECO/ MRC CTU/GCIG trials)
    Colomban, O.
    Tod, M.
    Leary, A.
    Ray-Coquard, I. L.
    Lortholary, A.
    Hardy-Bessard, A-C.
    Pfisterer, J.
    Du Bois, A.
    Kurzeder, C.
    Burges, A.
    Peron, J.
    Freyer, G.
    You, B.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] The predictive value of the CA-125 modeled kinetic parameter KELIM is validated in 3 independent datasets (AGO-OVAR 7 & 9; ICON 7 AGO/GINECO/GCIG trials)
    You, B. M.
    Colomban, O.
    Tod, M.
    Ray-Coquard, I. L.
    Lortholary, A.
    Hardy-Bessard, A. C.
    Du Bois, A.
    Huober, J.
    Meier, W.
    Kurzeder, C.
    Pfisterer, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [3] Preponderant impact of the chemosensitivity assessed by the modeled CA-125 kinetic parameter KELIM on the success of the first line treatment: Pooled analysis of AGO-OVAR 7, AGO-OVAR 9 and ICON7 trials-a GINECO-GINEGEPS study
    You, B.
    Tod, M.
    Leary, A.
    Ray-Coquard, I.
    Lortholary, A.
    Hardy-Bessard, A. C.
    Perren, T.
    Cook, A.
    Pfisterer, J.
    Bois, A. D.
    Kurzeder, C.
    Burges, A.
    Peron, J.
    Freyer, G.
    Colomban, O.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 339 - 340
  • [4] Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
    Colomban, Olivier
    Tod, Michel
    Leary, Alexandra
    Ray-Coquard, Isabelle
    Lortholary, Alain
    Hardy-Bessard, Anne Claire
    Pfisterer, Jacobus
    Du Bois, Andreas
    Kurzeder, Christian
    Burges, Alexander
    Peron, Julien
    Freyer, Gilles
    You, Benoit
    CLINICAL CANCER RESEARCH, 2019, 25 (17) : 5342 - 5350
1